pentylenetetrazole has been researched along with chrysin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calvo, D; Diaz, LE; Levi de Stein, M; Medina, JH; Paladini, AC; Peña, C; Wolfman, C | 1 |
| Afzal, O; Al-Abbasi, FA; Altamimi, ASA; Kazmi, I; Yang, Z; Zhang, Y; Zhao, J | 1 |
2 other study(ies) available for pentylenetetrazole and chrysin
| Article | Year |
|---|---|
Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties.
Topics: Animals; Anticonvulsants; Binding, Competitive; Flavonoids; Flunitrazepam; Mass Spectrometry; Mice; Pentylenetetrazole; Plant Extracts; Radioligand Assay; Receptors, GABA-A; Seizures | 1990 |
Neuroprotective role of chrysin-loaded poly(lactic-co-glycolic acid) nanoparticle against kindling-induced epilepsy through Nrf2/ARE/HO-1 pathway.
Topics: Animals; Carboxylic Ester Hydrolases; Epilepsy; Flavonoids; Heme Oxygenase-1; Kindling, Neurologic; Male; Nanoparticles; Neuroprotective Agents; NF-E2-Related Factor 2; Pentylenetetrazole; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2021 |